arrow
I

Ingrid Hedenfalk

Lund University
H指数:37
被引数:6,012

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer

一种整合的组学方法强调了表观遗传事件如何解释和预测乳腺癌对新辅助化疗和贝伐单抗的反应

2024-04-260
OAAI
Evaluation of the Sensitivity to Endocrine Therapy Index (SET2,3) in Early Male Breast Cancer: Results from an analysis in the EORTC 10085/TBCRC/BIG/NCTN International Male Breast Cancer Program
2023-03-010
PRE
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
2022-08-1635
OAAI
Evaluation of multiple transcriptomic gene risk signatures in male breast cancer
2021-07-266
OAAI
Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer
2021-04-0135
OAAI
Common Susceptibility Loci for Male Breast Cancer
2020-08-1214
OAAI
The genomic landscape of male breast cancers using the oncomine comprehensive assay for actionable mutations
2020-02-150
PRE
Extracellular lipid loading augments hypoxic paracrine signaling and promotes glioma angiogenesis and macrophage infiltration

细胞外脂质负荷增强缺氧旁分泌信号并促进胶质瘤血管生成和巨噬细胞浸润

2019-06-0724
OAAI
Evaluation of multiple transcriptomic gene risk signatures in male breast cancer
2019-02-150
PRE